GlassScriptPhysician profile
Silvana D Matte
NPI 1164657557
$3,560.37
in general payments reported to CMS, 2019-2025
35 companies · $829 in 2025
The $829 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.93 · 2022: $921 · 2023: $840 · 2024: $953 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,621.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $409.23 | 2019-2025 | Repatha, Evenity, Otezla |
| Novo Nordisk INC | $384.63 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $232.73 | 2022-2025 | Freestyle Libre 3 |
| Abbvie INC. | $228.46 | 2022-2025 | |
| Glaxosmithkline, LLC. | $201.65 | 2023-2025 | Shingrix, Arexvy |
| Dexcom, INC. | $193.46 | 2023-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $183.80 | 2023-2025 | Airsupra, Breztri |
| Exact Sciences Corporation | $166.64 | 2023-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $142.84 | 2024-2025 | Eohilia |
| Lilly USA, LLC | $124.66 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Sk Life Science, INC. | $116.19 | 2022 | |
| Pfizer INC. | $110.25 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $105.24 | 2022-2023 | |
| Ucb, INC. | $96.60 | 2022-2025 | Rystiggo, Nayzilam |
| Merck Sharp & Dohme LLC | $96.21 | 2022-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silvana Matte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.